%0 Journal Article %T CDK4/6抑制剂在消化道肿瘤中的研究进展
Research Progress of CDK4/6 Inhibitors in Digestive Tract Tumors %A 伊丽达娜·斯提瓦尔地 %A 毛睿 %J Advances in Clinical Medicine %P 2893-2897 %@ 2161-8720 %D 2023 %I Hans Publishing %R 10.12677/ACM.2023.133409 %X CDK4/6作为调节细胞周期的关键蛋白激酶,在衰老、DNA修复等行为中也扮演着重要的角色,对于CDK4/6以及其抑制剂的应用的相关研究也正在进行中,近年来成为在各种癌症类型中进行热点探究的潜在靶点。本文就CDK4/6抑制剂在消化道肿瘤治疗的研究进展进行讨论。
As a key protein kinase that regulates cell cycle, CDK4/6 also plays an important role in aging, DNA repair and other behaviors. Relevant studies on the application of CDK4/6 and its inhibitors are al-so in progress. In recent years, CDK4/6 has become a potential target for hot research in various cancer types. This article discusses the progress of CDK4/6 inhibitors in the treatment of digestive tract tumors. %K CDK4/6抑制剂,靶向治疗,消化道肿瘤
CDK4/6 Inhibitors %K Targeted Therapy %K Digestive Tract Tumors %U http://www.hanspub.org/journal/PaperInformation.aspx?PaperID=61999